Services

 
Orthotopic and Ectopic Implantation of Human and Mouse Xenografts

  • Breast Carcinoma
  • Lung Carcinoma
  • Skin Carcinoma
  • Leukemias
  • Lymphomas
  • Myelomas
  • Melanomas
  • Glioblastoma

Drug Administration Routes:

  • Intraperitoneal Injection
  • Food
  • Drinking Water
  • Oral Gavage

Blood Collection:

  • Tail Vein
  • Retro-orbital Vein

Services We Offer

Advanced Models of Primary Tumors and Metastasis Initiated by Orthotopic/Ectopic Implantation and Treated with Potential Drugs

Metastatic progression is a series of low efficacy steps. It starts with the invasion of primary tumor into the vicinity of blood or lymphatic vessels, continues with cancer cells entering circulation and getting trapped in narrow capillaries in the target organ as dormant micrometastases. Finally, they eventually form actively growing macrometastases that kill patients. Anti-metastatic activity of a potential drug can attack any of these steps to bring clinical benefit. However, drugs targeting the actively growing metastasis are ultimately the most desirable ones. BioTest4U staff has experience with simple and complex analyses of metastatic progression and primary tumor growth. This service is devoted to our customers from Biotech/Pharma companies, but also Food Industry customers that are interested in testing the cancer prevention and intervention potential of their compounds and food supplements.

We also provide services that allow testing drug efficacy in primary tumor models and chemically-induced models for chemoprevention studies.

Following detection systems are available for analyses of primary and metastatic lesions:

  • Histochemistry
  • Fluorescence imaging
  • Luminescence imaging
  • X-ray
  • Radioisotopic imaging
  • White light imaging

SIEMENS INVEON MULTIMODALITY SYSTEM, the MICRO-PET/CT/SPECT SYSTEM

PET (Positron Emission Tomography)
CT (Computerized Tomography, i.e. 3D X-Ray)
SPECT (Single Photon Emission Computed Tomography)

Images obtained by the above-listed approaches can be superimposed.

Pricing:

  • $600/mouse for genetic labeling of cells, orthotopic/ectopic implantation, one month of daily drug treatment, three months of animal housing followed by quantification of metastatic growth (number , size distribution average size).
  • $575/mouse for typical package of nude mice, xenograft implantation, one month of daily drug injection followed by two month primary tumor measurement with weekly reports and final evaluation
  • These prices are for orientation only.  Contact us for free estimate.



Metastatic Potential In Vitro

We provide analysis of metastatic potential in vitro by looking at single cell migration, collective cell migration, cancer cell proliferation and survival in the presence of normal host cells present in the organ where these metastasize. At the moment we provide a service called M-Spread Potential, which tests metastatic potential of cancer cells as well as anti-metastatic drug activity in 3D co-culture system with normal cells isolated from organs where breast cancer usually metastasize, i.e. lungs, liver, brain and bone.

  • Single cell migration
  • Collective cell migration
  • Breast Cancer M-Spread Potential
  • Breast Cancer M-Spread Drug Analysis

Pricing:

  •  Contact us for free estimate.



Isolation and Quantification of Circulating Cancer Cells

We process and analyze mouse models and patient samples. We detect all types of carcinoma cells, cell clusters and cell ghosts (nuclei-free particles with cell membrane/cytoskeleton) that are present in the white-blood cell fraction. No negative depletion that may eliminate clusters of cancer cells attached to normal cells.

Pricing:

  • Detection of Carcinoma Cells $580/sample (1-6 samples) $530/sample (6+).
  • Isolation of Carcinoma Cells $700/sample (1-6 samples) $650/sample (6+).
  • Isolation and Quantification of Carcinoma Cells $975/sample.



Chemosensitivity Testing

Personalized therapy is our ultimate goal.  We seek partnership with oncologists and other diagnostic laboratories to perform clinical trials and prospective studies on our chemosensitivity tests using live tumor samples. We provide testing in two- and three-dimensional cultures that mimic natural tumor growth, with or without normal cells that are likely to be part of the tumor in a given location, e.g. normal lung epithelial cells in the case of breast cancer that metastasize to lungs. We do small scale testing using conventional chemotherapeutic regimen and large scale testing using our chemical library.  Many of these drugs have been approved for indications other than cancer. Some have been shown to inhibit tumor growth in experimental animals or have a cancer preventive effect in humans.

Finally, we provide testing of selected candidate drugs in highly immunodeficient mice that are able to grow primary and metastatic samples from patients.

Disclaimer: These analyses are not covered by Medicare and other major insurance companies, because they are experimental in nature.  We provide scientific results obtained under conditions that closely mimic, but do not replicate exact conditions in human body. We provide results of scientific experiments, but do not provide medical advice.  You are fully responsible for all decisions made based on our testing.

 

Cancer Types:

  • Breast
  • Prostate
  • Lung
  • Skin


Culture:

  • Regular two-dimensional tissue culture
  • Three-dimensional tissue culture in semi-solid media

 
Compounds Tested:

  • Approved chemotherapy regiment compounds
  • Drugs originally approved for other indications than cancer
  • Natural substances
  • Food supplements

 
Pricing:

  • $3250 for up to 10 chemotherapeutic drug screen (5 samples minimum).
  • Price for large scale drug screening depends on the complexity of the project.
  • These prices are for orientation only.  Contact us for free estimate.

 

Additional Analyses and Services

  • Micro-PET Scanning (Useful for bone metastasis studies)
  • CUSTOM PROJECTS ARE WELCOME

 

 

© 2014 BioTest4U